
Stablecoin Development Corp
Pharmaceuticals
Stablecoin Development Corp (SDEV) Stock News
The latest SDEV headlines and market coverage — 2 recent stories, updated throughout the day.
- GlobeNewswire Inc.·
SDEV: Abbott Cooper PLLC Announces Investigation on Behalf of Stablecoin Development Corporation (Formerly Novabay Pharmaceuticals, Inc.) Stockholders
Abbott Cooper PLLC is investigating potential fiduciary duty breaches by the board of directors of Stablecoin Development Corporation (formerly NovaBay Pharmaceuticals, Inc.). The investigation targets stockholders who continuously held shares since prior to August 19, 2025. Similar investigations are also underway for Kalaris Therapeutics (formerly AlloVir) and Abundia Global Impact Group (formerly Houston American Energy Corp.).
- GlobeNewswire Inc.·
SDEV: Abbott Cooper PLLC Announces Investigation on Behalf of Stablecoin Development Corporation (Formerly NovaBay Pharmaceuticals, Inc.) Stockholders
Abbott Cooper PLLC is investigating potential fiduciary duty violations by the Board of Stablecoin Development Corporation (formerly NovaBay Pharmaceuticals, Inc.) in connection with a private placement of preferred stock. The investigation targets stockholders who held shares prior to August 19, 2025.